Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES IPCA LABS ALKEM LABORATORIES/
IPCA LABS
 
P/E (TTM) x 37.5 51.7 72.5% View Chart
P/BV x 6.5 5.4 121.4% View Chart
Dividend Yield % 1.0 0.3 313.3%  

Financials

 ALKEM LABORATORIES   IPCA LABS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
IPCA LABS
Mar-23
ALKEM LABORATORIES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3,6251,062 341.4%   
Low Rs2,835768 369.1%   
Sales per share (Unadj.) Rs970.1243.0 399.3%  
Earnings per share (Unadj.) Rs84.219.4 434.3%  
Cash flow per share (Unadj.) Rs110.229.7 370.9%  
Dividends per share (Unadj.) Rs50.004.00 1,250.0%  
Avg Dividend yield %1.50.4 354.1%  
Book value per share (Unadj.) Rs756.4230.3 328.5%  
Shares outstanding (eoy) m119.57253.70 47.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.8 88.4%   
Avg P/E ratio x38.447.2 81.3%  
P/CF ratio (eoy) x29.330.8 95.2%  
Price / Book Value ratio x4.34.0 107.5%  
Dividend payout %59.420.6 287.8%   
Avg Mkt Cap Rs m386,207232,120 166.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31412,876 165.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99361,642 188.2%  
Other income Rs m2,1611,518 142.4%   
Total revenues Rs m118,15363,160 187.1%   
Gross profit Rs m15,0659,033 166.8%  
Depreciation Rs m3,1042,616 118.7%   
Interest Rs m1,074482 222.8%   
Profit before tax Rs m13,0487,453 175.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9802,534 117.6%   
Profit after tax Rs m10,0684,919 204.7%  
Gross profit margin %13.014.7 88.6%  
Effective tax rate %22.834.0 67.2%   
Net profit margin %8.78.0 108.8%  
BALANCE SHEET DATA
Current assets Rs m86,06451,893 165.9%   
Current liabilities Rs m37,07118,058 205.3%   
Net working cap to sales %42.254.9 77.0%  
Current ratio x2.32.9 80.8%  
Inventory Days Days3351 63.6%  
Debtors Days Days676 1,145.7%  
Net fixed assets Rs m37,24534,336 108.5%   
Share capital Rs m239254 94.2%   
"Free" reserves Rs m90,20858,167 155.1%   
Net worth Rs m90,44758,420 154.8%   
Long term debt Rs m06,518 0.0%   
Total assets Rs m124,54186,229 144.4%  
Interest coverage x13.216.5 79.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.7 130.3%   
Return on assets %8.96.3 142.8%  
Return on equity %11.18.4 132.2%  
Return on capital %15.612.2 127.8%  
Exports to sales %14.642.9 34.0%   
Imports to sales %013.3 0.0%   
Exports (fob) Rs m16,91626,434 64.0%   
Imports (cif) Rs mNA8,178 0.0%   
Fx inflow Rs m16,91626,434 64.0%   
Fx outflow Rs m4,1908,178 51.2%   
Net fx Rs m12,72718,257 69.7%   
CASH FLOW
From Operations Rs m16,8258,058 208.8%  
From Investments Rs m1,128-7,250 -15.6%  
From Financial Activity Rs m-17,6085,072 -347.1%  
Net Cashflow Rs m4165,881 7.1%  

Share Holding

Indian Promoters % 56.7 46.3 122.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 44.8 54.5%  
FIIs % 8.5 10.3 82.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 53.7 80.5%  
Shareholders   65,184 82,809 78.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs IPCA Labs Share Price Performance

Period ALKEM LABORATORIES IPCA Labs S&P BSE HEALTHCARE
1-Day -1.18% 3.35% 1.18%
1-Month -0.99% 4.27% -0.75%
1-Year 52.26% 56.49% 61.82%
3-Year CAGR 21.70% 9.46% 18.16%
5-Year CAGR 22.99% 20.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.